An end-to-end cell and gene therapy development partnership
Cell and gene therapies are continuing to gain popularity, with 15 now FDA approved and hundreds more in development. While these treatments are promising, managing safety and effectiveness in patients is complex.
Around the world, research groups ranging from drug discovery, development, and manufacturing to clinical laboratories are using Bio-Rad’s Droplet Digital PCR technology as a reliable and scalable solution to myriad workflow challenges
From this Infographic, you will understand:
- The key benefits of ddPCR
- Why many industry actors trust ddPCR
And much more!
Explore Bio-Rad’s end-to-end solutions for developing and manufacturing cell and gene therapies at https://www.bio-rad.com/featured/en/cell-gene-therapy-resources.html
This content was provided by Bio-Rad.
